Gastrointestinal Diseases and Disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Can You Treat Irritable Bowel Syndrome With Cannabis? - High Times



High Times
 
Can You Treat Irritable Bowel Syndrome With Cannabis? 
High Times
... possible to fix that imbalance by consuming cannabis and putting additional cannabinoids into your system. A study published in 2005 reached similar conclusions. In this study, researchers concluded that medical cannabis alters the ?endogenous ...

 


Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results - GlobeNewswire (press release)



GlobeNewswire (press release)
 
Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results 
GlobeNewswire (press release)
Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The Company is developing Gimoti, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent ...
Evoke Pharma Schedules Conference Call and Webcast for Fourth ... Nasdaq

all 6 news articles » 


That discomfort in your stomach - New Straits Times Online



New Straits Times Online
 
That discomfort in your stomach 
New Straits Times Online
When it comes to abdominal discomfort, the cause could be either one of a number of serious gastrointestinal diseases such as stomach ulcers, gallstones or cancer, which cane lead to serious complications and life-threatening situations. Or, equally ...

 


Zacks Investment Research Upgrades Synergy Pharmaceuticals (NASDAQ:SGYP) to ?Buy? - StockNewsTimes



StockNewsTimes
 
Zacks Investment Research Upgrades Synergy Pharmaceuticals (NASDAQ:SGYP) to ?Buy? 
StockNewsTimes
Zacks Investment Research currently has $2.25 price target on the biopharmaceutical company's stock. According to Zacks, ?Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat ...
Zacks Investment Research Downgrades Synergy Pharmaceuticals (NASDAQ:SGYP) to Hold The Ledger Gazette
Somewhat Positive Press Coverage Somewhat Unlikely to Impact Synergy Pharmaceuticals (SGYP) Share Price Dispatch Tribunal
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Position Lifted by Wells Fargo & Company MN Week Herald
The Lincolnian Online  -Frisco Fastball  -BBNS  -Zacks 
all 103 news articles » 


Ritter Pharmaceuticals Appoints Distinguished Gastroenterologist, William Chey, MD, to Medical Advisory Board - GlobeNewswire (press release)



Ritter Pharmaceuticals Appoints Distinguished Gastroenterologist, William Chey, MD, to Medical Advisory Board 
GlobeNewswire (press release)
Dr. Chey is Nostrant Collegiate Professor of Gastroenterology & Nutrition Sciences, Director of the GI Physiology Laboratory, and Co-Director of the Michigan Bowel Control Program at Michigan Medicine. He also serves as a member of the Board of ...

and more » 


Mobile Endoscopic Workstations Market to Exhibit Impressive Growth During 2017 ? 2027 - Facts of Week



Mobile Endoscopic Workstations Market to Exhibit Impressive Growth During 2017 ? 2027 
Facts of Week
The mobile endoscopic workstations is surgical devices which are used for effective endoscopic surgeries. The mobile endoscopic workstations can accommodate all the required endoscopic devices that are used in an endoscopic surgery. Medical endoscopic ...

 


Gemphire to Host Expert Panel Call to Discuss Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) and NASH - GlobeNewswire (press release)



Gemphire to Host Expert Panel Call to Discuss Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) and NASH 
GlobeNewswire (press release)
She specializes in the treatment of gastrointestinal disease in children as well as fatty liver disease and obesity. She received an MD-MSPH from the University of Louisville School of Medicine and completed her pediatric residency in Louisville ...
Gemphire to Host Expert Panel Call to Discuss Pediatric ... - Nasdaq Nasdaq

all 1 news articles » 


ENTYVIOŽ (vedolizumab) Shows Higher Rates of Mucosal Healing Versus TNF?-Antagonist Therapy in Ulcerative ... - Canada NewsWire (press release)



ENTYVIOŽ (vedolizumab) Shows Higher Rates of Mucosal Healing Versus TNF?-Antagonist Therapy in Ulcerative ... 
Canada NewsWire (press release)
Recognizing this unmet need, Takeda and our collaboration partners have focused on improving the lives of patients through the delivery of innovative medicines and dedicated patient disease support programs for over 25 years. Takeda aspires to advance ...

and more » 


TV documentary spotlights ASU researchers' findings on autism-related gastrointestinal problems - Arizona State University



Arizona State University
 
TV documentary spotlights ASU researchers' findings on autism-related gastrointestinal problems 
Arizona State University
The World Health Organization estimates 1 in 160 children have autism spectrum disorder, which is characterized by some degree of impaired social behavior, communication and language. Symptoms begin in childhood and can persist through adolescence and ...

 


Gynecological Treatment Table Market: Business Opportunities, Current Trends, Market Forecast & North America ... - Facts of Week



Gynecological Treatment Table Market: Business Opportunities, Current Trends, Market Forecast & North America ... 
Facts of Week
and the actual process of whole Enterprise Gastrointestinal Drug market. In this introductory section, the research report incorporates analysis of definitions, classifications, applications and industry chain structure. Short Detail About ...

and more »